Edel Andreas, Jöbges Susanne, Weiss Bjoern, Paul Nicolas, Lyall Maike Lucia, Hoffmann Clemens, Schüürhuis Stephen, Piper Sophie K K, Konietschke Frank, Berger Elke, Busse Reinhard, Marschall Ursula, Kraufmann Ben, Witzenrath Martin, Eckardt Kai-Uwe, Spies Claudia
Department of Anesthesiology and Intensive Care Medicine (CCM | CVK), Charité - Universitätsmedizin Berlin, Berlin, BE, Germany.
Department of Nephrology and Intensive Medical Care, Charité - Universitätsmedizin Berlin, Berlin, BE, Germany.
BMJ Open. 2025 Sep 17;15(9):e098796. doi: 10.1136/bmjopen-2025-098796.
Patients receiving long-term ventilation (LTV) in out-of-hospital intensive care facilities often suffer from persistent impairments of their cognition, mental health and physical health, limiting their social participation. Chronically ill patients are often unable to express their care preferences. Thus, their medical care often lacks integration of patients' wishes and values. Telemedicine may be used to collect patient-reported outcome measures (PROMs) from these patients to align medical care with their preferences. Early integration of teleconsultation to provide rapid support for specific patient symptoms can reduce economic costs.
This is a multicentre, prospective, non-blinded, single-arm interventional trial with a pre-post design and follows the statement. 10 out-of-hospital intensive care facilities in Berlin and Brandenburg, Germany, are grouped into three clusters. The study population includes adult patients (≥18 years) receiving LTV and residing in participating care facilities. During the preintervention phase, standard patient care remains unchanged. From the start of the intervention phase, enrolled patients receive telemedicine rounds in addition to standard care. These telemedicine rounds, conducted at least weekly, involve on-site healthcare professionals, patients and their relatives. Data are collected at predefined time points-study months 1,3, 9, 15 and 21-with a target of 57 participants at each time point. The study aims to evaluate whether a structured telemedicine intervention (1) increases the proportion of patients receiving record-documented PROMs in routine care and (2) reduces hospital readmissions. Secondary outcomes include the evaluation of post-intensive care syndrome, healthcare costs and the usability, applicability and perceived benefits of telemedicine. Additionally, qualitative interviews with patients, their relatives and healthcare professionals will explore individual experiences with chronic critical illness, the perceived quality of life of the patients and how team members manage moral distress in caregiving contexts. A mixed-effects logistic regression model will be used to analyse patients' access to PROMs, while a mixed-effects Poisson regression model will be employed to evaluate hospital readmission rates. The findings may provide valuable insights into how telemedicine can improve patient-centred care for this particular patient group.
This study protocol received approval from the Ethics Committee of Charité-Universitätsmedizin Berlin, Germany (EA2/136/22). The findings will be disseminated through publication in a peer-reviewed scientific journal and presented at international conferences.
This study was registered in the 'German Register of Clinical Studies' (DRKS; DRKS00029326).
在院外重症监护机构接受长期通气(LTV)的患者常常存在认知、心理健康和身体健康的持续损害,限制了他们的社会参与。慢性病患者往往无法表达自己的护理偏好。因此,他们的医疗护理常常缺乏对患者意愿和价值观的整合。远程医疗可用于收集这些患者的患者报告结局指标(PROMs),以使医疗护理符合他们的偏好。早期整合远程会诊以为特定患者症状提供快速支持可降低经济成本。
这是一项多中心、前瞻性、非盲、单臂干预试验,采用前后设计并遵循相关声明。德国柏林和勃兰登堡的10家院外重症监护机构被分为三个集群。研究人群包括接受LTV并居住在参与的护理机构中的成年患者(≥18岁)。在干预前阶段,标准患者护理保持不变。从干预阶段开始,入组患者除接受标准护理外,还接受远程医疗查房。这些远程医疗查房至少每周进行一次,涉及现场医护人员、患者及其亲属。在预定时间点——研究第1、3、9、15和21个月——收集数据,每个时间点目标为57名参与者。该研究旨在评估结构化远程医疗干预是否(1)增加在常规护理中接受有记录的PROMs的患者比例,以及(2)减少医院再入院率。次要结局包括对重症监护后综合征、医疗成本以及远程医疗的可用性、适用性和感知益处的评估。此外,对患者、其亲属和医护人员进行的定性访谈将探讨慢性危重病的个人经历、患者感知的生活质量以及团队成员在护理环境中如何应对道德困扰。将使用混合效应逻辑回归模型分析患者获取PROMs的情况,同时采用混合效应泊松回归模型评估医院再入院率。这些发现可能为远程医疗如何改善针对这一特定患者群体的以患者为中心的护理提供有价值的见解。
本研究方案已获得德国柏林夏里特大学医学中心伦理委员会的批准(EA2/136/22)。研究结果将通过在同行评审的科学期刊上发表以及在国际会议上展示进行传播。
本研究已在“德国临床研究注册库”(DRKS;DRKS00029326)注册。